493 related articles for article (PubMed ID: 22586208)
1. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
Shanks KG; Dahn T; Behonick G; Terrell A
J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
[TBL] [Abstract][Full Text] [Related]
2. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
Ammann J; McLaren JM; Gerostamoulos D; Beyer J
J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
[TBL] [Abstract][Full Text] [Related]
3. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.
Ibáñez M; Bijlsma L; van Nuijs AL; Sancho JV; Haro G; Covaci A; Hernández F
J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959
[TBL] [Abstract][Full Text] [Related]
4. The role of ultra high performance liquid chromatography with time of flight detection for the identification of synthetic cannabinoids in seized drugs.
Marginean I; Rowe WF; Lurie IS
Forensic Sci Int; 2015 Apr; 249():83-91. PubMed ID: 25679986
[TBL] [Abstract][Full Text] [Related]
5. Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry.
Musah RA; Domin MA; Walling MA; Shepard JR
Rapid Commun Mass Spectrom; 2012 May; 26(9):1109-14. PubMed ID: 22467461
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel third-generation synthetic cannabinoids in products by ultra-performance liquid chromatography and time-of-flight mass spectrometry.
Shanks KG; Behonick GS; Dahn T; Terrell A
J Anal Toxicol; 2013 Oct; 37(8):517-25. PubMed ID: 23946450
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
[TBL] [Abstract][Full Text] [Related]
8. [Synthetic cannabinoids--the new "legal high" drugs].
Berkovitz R; Arieli M; Marom E
Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
[TBL] [Abstract][Full Text] [Related]
9. Acute kidney injury associated with smoking synthetic cannabinoid.
Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
[TBL] [Abstract][Full Text] [Related]
10. Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, "spice" and stimulants in oral fluid.
Strano-Rossi S; Anzillotti L; Castrignanò E; Romolo FS; Chiarotti M
J Chromatogr A; 2012 Oct; 1258():37-42. PubMed ID: 22939380
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction.
Kneisel S; Auwärter V
J Mass Spectrom; 2012 Jul; 47(7):825-35. PubMed ID: 22791249
[TBL] [Abstract][Full Text] [Related]
12. Direct analysis in real time mass spectrometry with collision-induced dissociation for structural analysis of synthetic cannabinoids.
Musah RA; Domin MA; Cody RB; Lesiak AD; Dane AJ; Shepard JR
Rapid Commun Mass Spectrom; 2012 Oct; 26(19):2335-42. PubMed ID: 22956326
[TBL] [Abstract][Full Text] [Related]
13. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
[TBL] [Abstract][Full Text] [Related]
14. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS.
Oiestad EL; Johansen U; Christophersen AS; Karinen R
Bioanalysis; 2013 Sep; 5(18):2257-68. PubMed ID: 24053241
[TBL] [Abstract][Full Text] [Related]
15. Designer drugs: a medicinal chemistry perspective.
Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples.
Salomone A; Gerace E; D'Urso F; Di Corcia D; Vincenti M
J Mass Spectrom; 2012 May; 47(5):604-10. PubMed ID: 22576873
[TBL] [Abstract][Full Text] [Related]
17. Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS.
Gottardo R; Chiarini A; Dal Prà I; Seri C; Rimondo C; Serpelloni G; Armato U; Tagliaro F
J Mass Spectrom; 2012 Jan; 47(1):141-6. PubMed ID: 22282100
[TBL] [Abstract][Full Text] [Related]
18. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.
Uchiyama N; Kikura-Hanajiri R; Ogata J; Goda Y
Forensic Sci Int; 2010 May; 198(1-3):31-8. PubMed ID: 20117892
[TBL] [Abstract][Full Text] [Related]
19. Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.
Seely KA; Patton AL; Moran CL; Womack ML; Prather PL; Fantegrossi WE; Radominska-Pandya A; Endres GW; Channell KB; Smith NH; McCain KR; James LP; Moran JH
Forensic Sci Int; 2013 Dec; 233(1-3):416-22. PubMed ID: 24314548
[TBL] [Abstract][Full Text] [Related]
20. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products.
Uchiyama N; Matsuda S; Kawamura M; Shimokawa Y; Kikura-Hanajiri R; Aritake K; Urade Y; Goda Y
Forensic Sci Int; 2014 Oct; 243():1-13. PubMed ID: 24769262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]